KKR Genetic Disorder L.P. - Significant Ownership

Signature - Title
/s/ Christopher Lee - Christopher Lee, Assistant Secretary, KKR Genetic Disorder GP LLC, its general partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by KKR Genetic Disorder L.P..

Significant Ownership of KKR Genetic Disorder L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share 7% $436M -$197M 13.3M -31.2% KKR Genetic Disorder L.P. May 12, 2025

Schedules 13D/G Reported by KKR Genetic Disorder L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.